Immunization, Hib3 in Belize
Belize: Immunization, Hib3 was 88.0% in 2024. ▼ Falling
Immunization, Hib3 in Belize, 2001–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
Belize recorded 88.0% for immunization, hib3 in 2024.
The figure is up 3.5% on the previous year and down 7.4% over ten years.
Over the whole period, immunization, hib3 in Belize peaked at 98.0% in 2006 and was at its lowest, 79.0%, in 2020.
That places Belize 114th out of 191 countries with data for 2024, putting it in the middle of the range.
The long-run direction has been consistently falling across the 24 years of available data.
Immunization, Hib3 in Belize, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 2001 | 96.0% | — |
| 2002 | 89.0% | -7.3% |
| 2003 | 96.0% | +7.9% |
| 2004 | 97.0% | +1.0% |
| 2005 | 96.0% | -1.0% |
| 2006 | 98.0% | +2.1% |
| 2007 | 96.0% | -2.0% |
| 2008 | 94.0% | -2.1% |
| 2009 | 97.0% | +3.2% |
| 2010 | 96.0% | -1.0% |
| 2011 | 95.0% | -1.0% |
| 2012 | 98.0% | +3.2% |
| 2013 | 95.0% | -3.1% |
| 2014 | 95.0% | +0.0% |
| 2015 | 94.0% | -1.1% |
| 2016 | 95.0% | +1.1% |
| 2017 | 88.0% | -7.4% |
| 2018 | 96.0% | +9.1% |
| 2019 | 98.0% | +2.1% |
| 2020 | 79.0% | -19.4% |
| 2021 | 83.0% | +5.1% |
| 2022 | 84.0% | +1.2% |
| 2023 | 85.0% | +1.2% |
| 2024 | 88.0% | +3.5% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 95.4% | 89.0% | 98.0% | 9 |
| 2010s | 95.0% | 88.0% | 98.0% | 10 |
| 2020s | 83.8% | 79.0% | 88.0% | 5 |
Countries ranked near Belize
- 114 Germany 88.0% compare
- 114 Palestine, State of 88.0% compare
- 117 Republic of Moldova 87.0% compare
- 117 Pakistan 87.0% compare
- 117 San Marino 87.0% compare
- 117 Sao Tome and Principe 87.0% compare
- 117 Solomon Islands 87.0% compare
More health data for Belize
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5114 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,415 deaths per 1,000 people (2090)
- Number of infants who die before age 1 9 deaths (2100)
- Population ages 50-54, male, annual growth rate 2.75 % change on previous year (2025)
- Population ages 50-54, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 50-54, male, per capita 0.0234 units per person (2025)
- Population ages 55-59, female, annual growth rate 4.51 % change on previous year (2025)
- Population ages 55-59, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 55-59, female, per capita 0.0197 units per person (2025)
Frequently asked questions
- What is immunization, hib3 in Belize?
- Immunization, hib3 in Belize was 88.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Belize?
- The highest recorded value was 98.0% in 2006.
- What is the lowest immunization, hib3 recorded in Belize?
- The lowest recorded value was 79.0% in 2020.
- How does Belize rank for immunization, hib3?
- Belize ranks 114th out of 191 countries with data for 2024.
- Is immunization, hib3 rising or falling in Belize?
- Over the last ten years it is down 7.4%. The long-run trend across the full record is falling.
- Where does this Belize data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 24 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.